REGENERON PHARMACEUT

REGN
Real-time Estimate Quote. Real-time Estimate  - 11/23 05:23:26 pm
522.145USD +0.66%
Prev.518.7400
Open538.8600
High538.8600
Low516.8000
Volume1 045 413
Latest news
3h ago
4h ago
8h ago
8h ago
Chart REGENERON PHARMACEUTICALS
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBullish
Resistance557589644
Spread/Res.-6,0%-11%-19%
Spread/Supp.1,7%1,7%11%
Support515515470
Financials
Sales 2020 8 591 M - -
Net income 2020 3 189 M - -
Net cash 2020 5 832 M - -
P/E ratio 2020 18,1x
Yield 2020 -
Capitalization 55 264 M 55 264 M -
EV / Sales 2020 5,75x
EV / Sales 2021 4,34x
Nbr of Employees 8 314
Free-Float 83,3%
Company
Regeneron Pharmaceuticals specializes in research, development, producing, and selling drugs used in treating ophthalmologic and inflammatory diseases and cancers. Sales break down by activity as follows:
- sales of products (61.5%);
- supply of collaborative services (33.3%): working with Sanofi...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2021-02-11 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 668,64 $
Last Close Price 518,74 $
Spread / Highest target 52,9%
Spread / Average Target 28,9%
Spread / Lowest Target -3,61%